Half of the participants attending ≥5 group sessions
3.9% attending all 10 sessions
25% did not attend any sessions
Overall gestational diabetes incidence: 6.7%
There was no difference in gestational diabetes incidence between the groups
GPNC: 7.1% | IPNC: 6.3%
Adjusted RD (aRD) 0.7% (95% CI, −1.2 to 2.7)
Among participants with gestational diabetes, GPNC did not reduce the risk of
Progression to gestational diabetes requiring treatment
aRD −6.1% (95% CI, −21.3 to 9.1
aRD −7.9% (95% CI, −17.8 to 1.9)
aRD −8.2% (95% CI, −12.2 to 13.9)
Large for gestational age
aRD −1.2% (95% CI, −6.1 to 3.8)
Gestational diabetes rates were similar in individuals who received group prenatal care, compared to traditional individual prenatal care
Previous observational studies did find benefit
Possible confounding in previous observational studies
In RCT, attendance was low vs observational studies where patients self-selected group prenatal care
The authors state
In this RCT among pregnant individuals, participants receiving GPNC had similar risk of developing GD, compared with participants receiving IPNC, suggesting that GPNC could be a feasible care option for some patients
Future studies should explore additional strategies to enhance participant engagement with GPNC
OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Jointly provided by
NOT ENOUGH CME HOURS
It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan